Polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS) after a 14-year global consultation involving patient groups and medical societies, addressing confusion caused by the misleading term 'polycystic.' The name change, announced at the European Congress of Endocrinology in Prague, aims to better reflect the hormonal disorder's complex effects on metabolism, reproduction, and cardiovascular health.
Topicle Beta
1 comment
Polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS) after a 14-year global consultation involving patient groups and medical societies, addressing confusion caused by the misleading term 'polycystic.' The name change, announced at the European Congress of Endocrinology in Prague, aims to better reflect the hormonal disorder's complex effects on metabolism, reproduction, and cardiovascular health.